Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury.
- 1 December 1992
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 71 (6) , 1518-1524
- https://doi.org/10.1161/01.res.71.6.1518
Abstract
Previous studies of myocardial ischemia suggest that complement activation may play a central role in the inflammatory response during reperfusion. Our previous work has demonstrated neutrophil chemotactic activity to be present in reperfusion canine cardiac lymph after myocardial ischemia and infarction. To evaluate the contribution of the complement-dependent anaphylatoxin C5a to this neutrophil chemotactic activity, rabbit antiserum to canine C5a was prepared. At dilutions > 1:500 but < 1:2,000, the antiserum abolished the ability of zymosan-activated dog serum to induce a ruffled, bipolar morphology in isolated neutrophils used as a bioassay of chemotactic stimulation. This antiserum did not affect similar morphological changes in neutrophils exposed to platelet activating factor (10(-7)-10(-6) M) or recombinant human interleukin-8 (10(-9)-10(-8) M); thus, we deemed it functionally specific for canine C5a. In a pattern similar to what we previously reported, cardiac lymph collected before a 1-hour ligation of the left circumflex coronary artery had little ability to alter the morphology of canine neutrophils (shape change index, 11.3 +/- 4.6, mean +/- SEM; n = 7), but by 1 hour of reperfusion, lymph activated neutrophils significantly in five of seven dogs (mean shape change index, 72.6 +/- 17.7; p < 0.01). At 2 hours of reperfusion, neutrophil activation by lymph occurred in six of seven dogs (mean shape change index, 103.1 +/- 22.2). At 3 hours of reperfusion, cardiac lymph of only three of six dogs caused neutrophil activation, and at 4 hours of reperfusion, this activity was evident in lymph from only two of five dogs.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 14 references indexed in Scilit:
- Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8Science, 1991
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- The role of leukocytes in ischemic damage, reperfusion injury and repair of the myocardiumPublished by Springer Nature ,1990
- Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusionJournal of the American College of Cardiology, 1988
- High-level C5a gene expression and recovery of recombinant human C5a fromEscherichia coliInflammation Research, 1987
- A potent mercapto bi-product analogue inhibitor for human carboxypeptidase NBiochemical and Biophysical Research Communications, 1981
- Fifth component of human complement: purification from plasma and polypeptide chain structureBiochemistry, 1979
- Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery OcclusionJournal of Clinical Investigation, 1978
- Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.Journal of Clinical Investigation, 1975
- THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATSThe Journal of Experimental Medicine, 1971